Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Watch Out for a Selloff in Vaxart Stock

By Chris Lau, InvestorPlace Contributor
Vaxart needs a Covid-19 vaccine approved and selling on the market before the established mega-cap names take all the sales.

7 Travel Stocks to Sell if the Delta Variant Slows the Reopening Rally

By Thomas Niel, InvestorPlace Contributor
Yet, with millions in the U.S. not vaccinated, and uncertainty over the effectiveness of the current vaccines against this variant? Travel stocks, still priced based on "pent up demand," and a fast "return to normal," may be in for big declines in the second half of 2021. So, ahead of possible continued pullback, which travel stocks should you take profit on? If you own any of these seven vaccine recovery winners, it may be high time to cash out: American Airlines (NASDAQ:AAL) Airbnb (NASDAQ:ABNB) Caesars Entertainment, Inc. (NASDAQ:CZR) OneSpaWorld (NASDAQ:OSW) Marriott International (NYSE:MAR) MGM Resorts International (NYSE:MGM) Royal Caribbean (NYSE:RCL)

Workhorse Stock Rallied, but It’s Clear There’s No Gas in That Tank

By Chris Lau, InvestorPlace Contributor
Workhorse is trading on the hope that the USPS lawsuit will revive the bidding review and earn a much-needed contract.

Marathon Digital Is Being Dragged Down by the Cryptocurrency Market

By Joel Baglole, InvestorPlace Contributor
Marathon Digital Holdings, which specializes in mining Bitcoin and other cryptocurrencies has enjoyed a spectacular run in the past six months. Year-to-date, MARA stock is up 186% at $31.49 a share. However, the company's stock price peaked at $57.75 a share in April. Since then, the share price has fallen 46%. Not surprising, the decline in Marathon Digital's stock has mirrored the fall in various cryptocurrencies.

Orphazyme’s Massive Price Appreciation Won’t Be Captured Again

By Alex Sirois, InvestorPlace Contributor
ORPH stock multiplied overnight to lofty highs, but it clearly won't happen again due to its very small market capitalization.

MindMed Stock Is Overvalued and Too Risky to Own

By Stavros Georgiadis, CFA, InvestorPlace Contributor
MindMed can be the future of psychedelic medicines, but without cash flow from revenue, MNMD stock is nothing to get excited about.

Lay Off Li Auto Stock Until the Chinese EV Sector Shows Signs of Cooling

By Josh Enomoto, InvestorPlace Contributor
Although LI stock should be enjoying robust upside thanks to encouraging deliveries, it’s not. Here are some possible reasons why.

Stay Away From Low-Growth Organon

By Larry Ramer, InvestorPlace Contributor
Organon's low growth, lack of strong catalysts and likely average future dividend combine to make OGN stock unattractive.

MicroVision Stock Is Still Overvalued Despite Bullish Sentiment

By Chris Markoch, InvestorPlace Contributor
Despite support from Reddit traders and the potential for explosive growth in its sector, there are signs that MVIS stock is overvalued.  

AMC Investors Can Learn From IMAX

By Wayne Duggan, InvestorPlace Contributor
AMC stock has skyrocketed to new all-time highs in 2021. But the movie theater business is struggling, and IMAX better reflects that trend.

Bank of America Stock Is Likely Going into Headwinds

By Nicolas Chahine, InvestorPlace Contributor
Giant money centers are fortresses but I expect headwinds this year. BAC stock resistance is posing more downside risk than upside potential.

Palantir Needs Social Media Buzz to Maintain Its Rich Valuation

By Ian Bezek, InvestorPlace Contributor
The glitz of Palantir's AI business has long been stronger than its actual operating results. Beware if the hype of PLTR stock fades.

Read Between the Lines on Penn National Gaming To See All Bets Are Off

By Josh Enomoto, InvestorPlace Contributor
While PENN stock benefits from the fundamental catalyst of sports betting legalization, it’s not quite as charming as you might think.

Ocugen Has Had a Good Run, but the Math Says It’s Over

By Chris Markoch, InvestorPlace Contributor
Ocugen was a penny stock is up 180% for the year.  But all good things must come to an end. And it’s time to let go of OCGN stock. 

Stay Away from Aspiring Squeeze Play Workhorse Stock

By Thomas Niel, InvestorPlace Contributor
In the meantime, those long WKHS stock could get impatient. If they cash out, shares will continue to drift lower from today's prices (around $15.50 per share). Even if you are more bullish on its chances of winning its fight over the USPS bid, the best move may be to hold off for now.

Despite Encouraging News, Lordstown’s Shares Still Look Poised to Plunge

By Larry Ramer, InvestorPlace Contributor
With Lordstown still lacking "binding" orders and facing a cash crunch, RIDE stock is likely to tumble sooner or later.

Clover Health Is a Worsening Stock, Only Held Higher by Short Interest

By Alex Sirois, InvestorPlace Contributor
CLOV stock has only continued to get sicker and sicker since coming public not long ago. Now its troubles are compounding. Steer clear.

7 Stocks to Sell as You Head Into July 2021

By Faisal Humayun, InvestorPlace Contributor
These stocks to sell have stretched valuation, but their fundamentals are robust and these stocks are worth accumulating on a correction.

RSVP ‘No’ to the Lucid Motors Party Before CCIV Stock Crashes

By Joanna Makris, Head of Equity Research, Boardroom Alpha
Riding the momentum train in CCIV stock? Make sure you know when to exit. The market will soon pull out its own measuring stick to judge it.
Load More Articles